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same class are closely related to each other and which are 
not. The presented associations between antibiotics may be 
helpful in selecting the proper therapy directions. Here we 
present an adaptation of interdisciplinary studies of drug 
resistance of E. coli strains for epidemiological and clinical 
investigations. The obtained results may be some indication 
in deciding on antibiotic therapy.
Keywords UPEC · Drug resistance · Differentiation · 
ATR/FT-IR
Introduction
The observed increase of drug resistance among bacteria 
forces to seek still new solutions to this problem [1, 2]. 
This is also an interesting issue for studying the mecha-
nisms and correlations between bacteria, antibiotics and the 
host [3]. A very useful tool for data analysis is mathemati-
cal modeling which is increasingly used in biology, with 
particular success in epidemiology [4, 5]. This method uses 
theoretical assumptions and mathematical tools for assess-
ing the dynamics between antibiotic consumption and the 
occurrence of antimicrobial resistance [6]. Mathematical 
modeling allows to analyze complex relationships among 
interdependent parameters [7]. There are many factors 
that influence the acquisition of resistance in bacteria and 
modulate antibiotic resistance patterns. The significance 
of individual factors is difficult to determine and the math-
ematical analysis may be helpful here. The value of these 
factors may be crucial for the investigation of changes in 
antibiotic resistance [4]. Mathematical modeling is appro-
priable to the study of dynamics of this phenomenon and 
predicts its development [6, 8]. Another use of modeling 
is guiding clinical practice. For example, this method may 
Abstract Bacterial drug resistance and uropathogenic 
tract infections are among the most important issues of cur-
rent medicine. Uropathogenic Escherichia coli strains are 
the primary factor of this issue. This article is the continu-
ation of the previous study, where we used Kohonen rela-
tions to predict the direction of drug resistance. The char-
acterized collection of uropathogenic E. coli strains was 
used for microbiological (the disc diffusion method for 
antimicrobial susceptibility testing), chemical (ATR/FT-IR) 
and mathematical (artificial neural networks, Ward’s hier-
archical clustering method, the analysis of distributions of 
inhibition zone diameters for antibiotics, Cohen’s kappa 
measure of agreement) analysis. This study presents other 
potential tools for the epidemiological differentiation of E. 
coli strains. It is noteworthy that ATR/FT-IR technique has 
turned out to be useful for the quick and simple identifi-
cation of MDR strains. Also, diameter zones of resistance 
of this E. coli population were compared to the population 
of E. coli strains published by EUCAST. We observed the 
bacterial behaviors toward particular antibiotics in com-
parison to EUCAST bacterial collections. Additionally, 
we used Cohen’s kappa to show which antibiotics from the 
 * Wioletta Adamus-Białek 
 aloiv2002@wp.pl; wioletta.adamus-bialek@ujk.edu.pl
1 Institute of Medical Sciences, Jan Kochanowski University, 
IX Wieków Kielc 19A Av., 25-317 Kielce, Poland
2 Department of Microbiology, Institute of Biology, 
Jan Kochanowski University, 15 Swietokrzyska St., 
25-406 Kielce, Poland
3 Institute of Mathematics, Jan Kochanowski University, 15 
Swietokrzyska St., 25-406 Kielce, Poland
4 Institute of Medical Biology, Polish Academy of Sciences, 
106 Lodowa St., 93-232 Lodz, Poland
192 Mol Biol Rep (2017) 44:191–202
1 3
be used to determine the appropriate antibiotic therapy to 
prevent the induction of resistance [1, 9]. The combina-
tion therapy with two antimicrobial agents at the early 
stages of the infection represent an example of the effects 
of this research. Mathematical analysis is most often used 
also for case-control studies. The case-control design is 
well adapted to the identification of rare outcomes, such 
as infection with resistant microorganisms. In literature we 
can also find Cohort analysis to determine the incidence of 
disease or antibiotic resistance in different studied groups 
[2, 4, 5]. Additionally, the associations between antimi-
crobial exposure and resistance at the bacterial group level 
are investigated by using a correlation coefficient based on 
aggregate data as the measure of association [4, 5]. Another 
approach, meta-analysis, is a type of systematic survey 
that applies statistical techniques to include the different 
research results and arrive at a single quantitative summary 
(a weighted average) [6].
In recent years, epidemiologists noticed a rapid increase 
of resistance among pathogenic bacteria species [1, 2, 4, 5, 
10]. Uropathogenic Escherichia coli strains (UPEC) belong 
to this group so they are frequently analyzed bacterial spe-
cies. These bacteria are widespread in the hospital environ-
ment and possess mobile genetic elements which take part 
in the spreading of virulence factors and antibiotic resist-
ance [8]. The most likely cause of acquiring resistance is 
the inappropriate use of antibiotics to treat bacterial infec-
tions [10]. This process becomes increasingly problematic 
due to the emergence of resistance to several antimicrobial 
agents, including extended-spectrum cephalosporins, fluo-
roquinolones, and aminoglycosides [8, 11]. Recent reports 
show that quinolones are prescribed in nearly 50% of all 
outpatient urinary tract infection (UTI), although cur-
rent guidelines recommend against their use as a first-line 
treatment for uncomplicated UTIs. As a result, the spread 
of quinolone-resistant pathogens, particularly E. coli are 
on the rise globally [12]. It is important to determine the 
pathogen resistance and identify the appropriate antibiotic. 
Such a procedure enables the patient to recover quickly 
and, in most cases, it does not result in chronic diseases. 
Susceptibility testing can be done in a number of ways, but 
the simplest one is to use the method of radial diffusion 
[11].
Some studies especially emphasize the role of anti-
biotic consumption in the development of antimicrobial 
resistance in bacteria [4]. It is well known that the use of 
antibiotics can lead to the emergence of bacterial resist-
ance [6]. The reasons can be gene mutations, horizontal 
gene transfer and recombination or changes in the regu-
lation of gene expression, which can influence the con-
struction of the bacterial wall or produce antibacterial 
proteins. The development of the population of antibi-
otic-resistant bacteria and their worldwide distribution 
are the consequence of long years of selective pressure 
on the grounds of antibiotics underuse, overuse, as well 
as misuse [13].
Certain antibiotic classes induce resistance more often 
than others due to the mechanism of action against bacte-
ria. Antibiotic resistance generally arises through mecha-
nisms such as horizontal gene transfer and selection of 
naturally occurring mutants [4–6, 13]. Cross resistance 
is a commonly known phenomenon causing resistance 
to a similarly acting substance. For example, a lot of E. 
coli strains resistant to tetracycline are also insensitive to 
fluoroquinolones [11]. The mechanism of cross resistance 
is extremely complicated and unknown, but the most 
probable cause of this phenomenon would be that chemi-
cally dissimilar agents may interfere with the same meta-
bolic pathways. Another explanation is that resistance in 
a specific case would arise by mutation at one or a few 
genetic loci, and these mutations result in several phe-
notypic changes related to origin but are diverse in their 
effect [14].
Antibiotic resistance patterns are generated for prac-
tical reasons. Any drug resistance analyses are essential 
to discovering the correlations between antibiotics and 
pathogens and therapy [5]. Analyses of bacterial sensitiv-
ity to antibiotics are important for determining the proper 
dose of antibiotic applied during infection. There are 
many techniques for differentiating bacteria. Presently, 
genotyping as PFGE, MLST or PCR based on repeated 
sequences are the most popular [12, 15–20]. Also the 
drug resistance patterns can be a potential method for the 
epidemiological differentiation of bacterial strains which 
are difficult to distinguish. The profiles of antibiotic sen-
sitivity can be linked with genetic, chemical and/or math-
ematical analysis. This interdisciplinary approach can 
deliver a lot of information about the mechanisms of bac-
terial resistance to antibiotics in their environment [21]. 
In our previous publication we demonstrated, accord-
ing to mathematical analysis by Kohonen networks, that 
clustering of UTI bacteria may depend on resistance/
sensitive patterns [8]. In the presented study, the same 
collection of E. coli strains were tested for their drug-
resistance profiles of 37 antibiotics. First, the obtained 
IR bacterial spectra correlated with elaborated artificial 
neural network were used for the identification of MDR 
strains from the collection. Next, agglomeration accord-
ing to Ward’s was used as a tool for deep clonal differ-
entiation of E.coli strains. We also compared the strains 
between each other based on the 1  mm coincidences of 
diameter zones of inhibited growth by particular antibiot-
ics. Finally, we present the potential method for creating 
a model for a new look at antibiotic selection during ther-
apy. We use Cohen’s kappa for the observation of specific 
relationships between antibiotics from the same class.




In this study we used a collection of 107 clinical E. coli 
strains isolated from the urine of patients in different 
wards of military teaching hospital no. 2, medical uni-
versity of Łódź, Poland in the years 2005–2007. Clinical 
E. coli strains were collected based on the presence of 
>104 CFU/ml of bacteria in urine. E. coli ATCC 25922 
was used as a control during an antimicrobial disc dif-
fusion test. The strains were previously characterized 
based on the presence of virulence factor genes, phy-
logenetic groups, TRS profiles and drug resistance for 
18 antibacterial agents [12]. This collection was later 
redefined according to the new phylotyping Clermont’s 
protocol [22], presence of virulence factors according 
to Adamus-Białek et  al. protocol [12] and Muller et  al. 
protocol [23], and TRS-PCR profiles were performed as 
it was mentioned above [12] (Kubiak-Szeligowska, A., 
Majchrzak, M., Bartnicka M., 2013, data not shown). 
The analyzed virulence factor genes were: papC, 
sfaD/sfaE, cnf1, usp, hlyA, fimG/fimH.
Antibiotic susceptibility testing
Antimicrobial susceptibility testing of bacteria was done 
using the disc diffusion method with commercial discs 
(Oxoid, Wesel, Germany), according to the guidelines 
of EUCAST 2015. A standardized inoculum of bacteria 
(0.5 McFarland standard) were swabbed onto the surface 
of Mueller–Hinton agar plates (Graso). Filter paper discs 
impregnated with antimicrobial agents were placed on 
the agar surface. After 18 ± 2  h of incubation at 35 °C, 
the diameter of the inhibition zone around each disc was 
measured, and these measurements were compared with 
the EUCAST disc diffusion tables. Bacterial isolates 
were determined to be sensitive (S), intermediate (I), or 
resistant (R) to the antimicrobial agents tested.
The isolates were tested against 37 antimicrobials: 
amikacin, amoxicillin, amoxicillin.clavulanate, ampi-
cillin, ampicillin + sulbactam, aztreonam, cefadroxil, 
cefalexin, cefepime, cefixime, cefotaxime, cefoxitin, cef-
tazidime, ceftibuten, ceftriaxone, cefuroxime, chloram-
phenicol, ciprofloxacin, doripenem, ertapenem, fosfo-
mycin, gentamicin, imipenem, levofloxacin, mecillinam, 
meropenem, moxifloxacin, nalidixic.acid, netilmicin, 
norfloxacin, ofloxacin, piperacylline, piperacillin + tazo-
bactam, ticarcillin, ticarcillin + clavulanic acid, tigecy-
cline, tobramycin. The analysis was repeated three times 
for ten randomly selected strains.
Chemical analysis
The bacterial IR spectra were measured using a “Spec-
trum 400” spectrometer (Perkin Elmer) in attenuated total 
reflectance technique (ATR). Detailed conditions of bac-
terial culture and measurement of infrared spectra were 
described in previous studies [24]. Briefly, bacteria were 
grown on LB medium at 37 °C for 24 h. After this time the 
IR spectrum of a single bacterial colony was measured in 
the range 4000−750 cm−1 with an accuracy of 1 cm−1, at 
a constant temperature and air humidity. For each strain 20 
infrared spectra were measured. Then, the first derivatives 
of absorbance were calculated using five-point stencil and 
the derivatives were scaled to the range {0–1}.
Mathematical analysis
The results obtained from drug resistance analysis of the 
studied strains were used for different mathematical meth-
ods. MS Excel and Statistica 10 applications were used 
for data processing of IR spectra and the design of artifi-
cial neural networks. The Euclidean distances between all 
pairs of strains were calculated and then Ward’s hierarchi-
cal clustering method was applied. Bacterial differentiation 
was performed based on the diameter zone (mm) of inhib-
ited growth on a plate with antibiotics discs. Also, the dis-
tributions of inhibition zone diameters for antibiotics were 
analyzed. Additionally, the relationships between antibi-
otic effects on the bacteria (resistance, sensitivity) were 
analyzed using Cohen’s kappa measure of agreement. The 
correlation with p-value < 0.05 was statistical significant. 
R package irr [(Matthias Gamer, Jim Lemon and Ian Fel-
lows Puspendra Singh < puspendra.pusp22@gmail.com> 
(2012). irr: Various coefficients of interrater reliability and 
agreement. R package version 0.84)] was used to calculate 
Cohen’s kappa.
Results and discussion
Application of IR spectrometry and artificial neural 
network for the identification of MDR strains
Antimicrobial susceptibility testing of 107 E. coli strains 
for 37 antibiotics was the starting point for further analysis. 
Based on the disc-diffusion test we identified 41% MDR 
strains of the total collection of E. coli strains. The diverse 
and valuable approach in the analysis of drug resistance 
turned out to be IR analysis of bacterial spectra in correla-
tion with artificial neural network. It was shown, that this 
chemical analysis can also detect these MDR strains. The 
first derivatives of spectra were used for learning the arti-
ficial neural networks (Fig.  1). The IR spectra collection 
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was divided randomly into 3 subgroups: 70% of the spec-
tra were included in the learning group, 15% of the spectra 
were included in the testing group, 15% of the spectra were 
included in the validation group. Evaluation of the quality 
of artificial neural networks was performed on the basis 
of an error made in the validation group. The best of the 
neural network recognized properly 92.13% spectra of the 
bacterial strains in the validation group (Table 1). A similar 
analysis were published previously. The data of IR bacterial 
spectra were analyzed in correlation with the gene papC 
[25] and susceptibility for cephalotin [24]. We used the 
same collection of E. coli strains. This method confirmed 
again its usefulness for the differentiation of bacterial 
strains. The wide spectrum of organic compounds seen by 
IR and interpreted by artificial neural network is a great, 
useful tool for quick screening of clinical bacteria, which 
can be dangerous and important for epidemiology risk. The 
results can be obtained the next day and the diagnostics do 
not require the preparation of the time-consuming disc dif-
fusion test. It can be a new convenient approach for identi-
fying specific properties of other bacterial species. Muham-
adali et al. [26] presented similar studies on Campylobacter 
sp. They obtained clear bacterial differentiation using Fou-
rier transform infrared (FT-IR) and Raman spectroscopies, 
Fig. 1  The example of infrared spectrum of uropathogenic E. coli strain (No. 41); windows 1—lipids, windows 2—proteins, windows 3—
nucleic acids, windows 4—carbohydrates, windows 5—fingerprint region
Table 1  The characteristics of artificial neural networks that recognize E. coli MDR strains











Learning algorithm Error function Activation func-
tion in hiden 
layer
Activation func-
tion in output 
layer
1 50-8-2 3.54 8.92 7.87 BFGS 156 SOS Exp Linear
2 50-9-2 3.2 9.19 8.92 BFGS 158 SOS Exp Linear
3 50-10-2 3.66 7.87 8.92 BFGS 123 SOS Exp Tanh
4 50-9-2 4.22 9.45 9.19 BFGS 114 SOS Exp Linear
5 50-10-2 4.95 8.4 9.45 BFGS 112 SOS Exp Tanh
6 50-8-2 6.86 9.45 9.71 BFGS 156 SOS Exp Exp
7 50-9-2 5.91 10.24 9.71 BFGS 136 SOS Exp Exp
8 50-9-2 4.44 8.66 9.71 BFGS 102 SOS Exp Linear
9 50-10-2 3.6 7.61 9.97 BFGS 128 SOS Exp Linear
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together with matrix-assisted laser desorption ionisation-
time of flight-mass spectrometry (MALDI-TOF-MS), as 
physicochemical approaches for generating biochemical 
fingerprints. Also Piras et al. [27] used the same technique 
for bacterial differentiation based on their resistance to 
enrofloxacin. They also discovered differentially expressed 
proteins principally involved in antibiotic resistance and 
linked to oxidative stress response, to DNA protection and 
to membrane permeability. Elsewhere, Gurbanov et al. [28] 
used FT-IR spectra for the differentiation of bacteria based 
on their resistance to heavy metals. We believe that IR 
bacterial spectra also has great potential in epidemiologi-
cal differentiation of many species and their features. The 
broad metabolic and genetic analysis provides new infor-
mation about bacteria and can even be helpful for devel-
oping vaccines against UTI [29]. It should be remembered 
that bacterial resistance is commonly related to other bacte-
rial properties and mechanisms not directly associated with 
drug resistance. Understanding the molecular level of those 
mechanisms is highly important to monitor multi-resistant 
strains and to expand new therapeutic strategies [30].
Bacterial differentiation based on diameter zone 
of drug resistance
The reactions of 107 E. coli strains to 37 antibiotics were 
analyzed by Ward’s hierarchical clustering method. Strains 
were differentiated based on the diameter zone values 
(mm) of inhibited growth on a plate with antibiotic discs 
(Fig. 2). The Y axis presents values of the similarity level 
between bacterial strains. The analysis showed that all 
strains present different profiles of reaction to antibiotics. 
However, some strains were grouped based on similarity to 
each other. The four main clusters were identified in den-
drogram. Further, this kind of differentiation revealed a 
correlation with some kind of bacterial features identified 
previously [12]. Strains were analyzed based on the viru-
lence factors (VFs) genes specific for uropathogenic E. coli 
strains (papC, sfaD/sfaE, cnf1, usp, hlyA) and fimG/fimH 
gene specific for the majority of E. coli isolates. The stud-
ied collection of the bacteria was divided into two groups: 
with and without VFs genes. Strains with virulence fac-
tors possessed at least one uropathogenic VFs gene and 
fimG/fimH in contrast to the second group of strains lack-
ing UPEC-specific virulence factors. The analysis of the 
dendrogram is presented in Table 2, in detail. The bacterial 
strains with the virulence factor genes are rarely present in 
clusters I and III. Additionally, cluster III represents MDR 
strains. In contrast, clusters II and IV represent most strains 
with the virulence factor genes (approx. 65% of the strains 
from these clusters) and they are characterized by a lower 
level of drug resistance. It is worth noting that relatively 
low coefficients of variation between strains in cluster II 
suggest high similarity of the reaction of these strains to all 
antibiotics. Furthermore, 67% of these strains possess ana-
lyzed virulence factors. It means, that cluster II represents 
the most numerous and the most homogeneous group of E. 
coli strains. Additionally, among this cluster strains no.: E4, 
E40, E81, E98, E105 and E114 are very similar. They were 
sensitive to 27 of the same antibiotics and their reaction to 
those antibiotics was almost identical. A similar correlation 
was observed by CGG-PCR method presented in the previ-
ous study. It should be noted, that this is further proof that 
drug resistance is strongly correlated with the virulence 
factors of E. coli strains [12]. It is worth adding that the 
dependency between the gender of the host and bacterial 
resistance have been presented in the literature [31–33], but 
this correlation was not observed in our study, which may 
be the result of the fact that the number of strains obtained 
from male is not representative (25% of bacterial collection, 
data not shown). The relationship between bacterial resist-
ance and other features are often described in literature. For 
Fig. 2  The differentiation of the E. coli strains based on the inhibition zones diameters to particular antibiotics according to Ward’s agglomera-
tion method
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example, advanced molecular studies reveal the importance 
of quorum sensing [30] and oxidative stress response [27] 
to bacterial resistance to antibiotics.
Furthermore, we have differentiated these uropathogenic 
E. coli strains based on the coincidence up to 1 mm of the 
identified diameter zone of inhibited growth by particular 
antibiotics. The 1 mm was tagged as a critical value of the 
bacterial reaction to the antibiotic on the plate. All drug 
resistance profiles of the strains were compared to each 
other which gave 5671 combinations. The level of bacterial 
coincidences based on diameter zones of inhibited growth 
was presented in Table 3. Only five pairs of strains had no 
coincidence up to 1 mm of diameter zones of any antibiot-
ics. Also, the coincidence was observed for one antibiotic 
in the case of 50 paired strains representing only 1% of all 
combinations. Most of the similarities between drug resist-
ance profiles occurred for 13–30% of antibiotics. The coin-
cidences for more antibiotics were increasingly rare. The 
highest similarity was observed only for one pair of strains. 
They had coincidence up to 1  mm of diameter zones of 
27 antibiotics (which represents 73% of used antibiotics). 
To conclude, these methods of drug resistance analysis 
could be alternative methods for bacterial differentiation. 
They present very deep differentiation of the strains, but it 
depends on the cut of value of the similarity level. These 
methods of differentiation may also be used as a poten-
tial tool for the epidemiological investigation of infection 
paths. Strain differentiation is needed to determine clonal 
transmission in disease sources, to confirm cross-infec-
tion in healthcare settings, or to discover evolutionary 
diversity among bacteria. Nowadays, the most frequently 
used method for deep differentiation of bacterial strains is 
genotyping. In the previous study we also proposed a new 
method for clonal genotyping of the same bacterial collec-
tion [12]. The (CGG)4 sequence used in primers for PCR 
reaction proved to be a great tool for the differentiation of 
bacteria based on their pathogenic properties. Also other 
repeated sequences or specific genetic regions are adapted 
for genotyping e.g. ERIC [12, 34, 35], REP, RAPD, BOX, 
[15, 36]. The more frequently used techniques involve 
multilocus sequence typing (MLST), pulsed-field gel 
electrophoresis (PFGE), restriction fragment length poly-
morphism (RFLP) studies [16–20]. An old method of dif-
ferentiation concerns phenotyping as enzyme profiles of 
bacterial strains [37–40]. Multilocus enzyme electrophore-
sis (MLEE) could be compared to the analysis of antibiotic 
zones of inhibition. Resistance to beta-lactams is mainly 
due to the production of enzymes—betalactamases, which 
might reveal some correlations between these analyses.
Behavior groups of E. coli based on drug resistance 
profiles
The analyses were performed based on the distribution of 
diameter zones of the growth inhibition of all strains for 
the particular antibiotics. The results were compared to 
the similar data presented by EUCAST [1, 9]. This source 
is often used by other scientists to compare their obtained 
results to the antibiotic resistance of reference strains 
published by EUCAST or CLSI. These organizations are 
Table 2  The characteristics of the dendrogram (Fig. 2)
Cluster No. of strains All strains restistant to antibiotics (class) All strains sensitive to % of strains with 
virulence factors 
genes
1 19 Nalidixic acid (quinolones)
close to tigecycline (others)
Mecillinam (penicillins); ampicillin.sulbactam 
(penicillin comb.);
Cefadroxil, ceftriaxone (cephalosporins 3);
Meropenem (carbapenems)
21
2 43 Tigecycline (others) Mecillinam (penicillins); ampicillin.sulbactam 
(penicillin comb.);
Meropenem (carbapenems);
Cefalexin (cephalosporins 1); cefadroxil (cepha-
losporins 3)
67
3 15 Amoxicillin, ampicillin, piperacylline, ticarcil-
lin (penicillins); Ticarcillin.clavulanic.acid 
(penicillin comb.);
Ciprofloxacin, levofloxacin, moxifloxacin, nali-
dixic.acid, norfloxacin, ofloxacin, (quinolones);
Tigecycline (others)
Doripenem, meropenem (carbapenems) 13
4 30 Tigecycline (others);
close to: piperacylline (penicillins); 
Ticarcillin.clavulanic.acid (penicillin combina-
tions)
Meropenem, close to ertapenem (carbapenems) 63
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created to control and estimate the clinical breakpoint 
changes and their impact on surveillance of antimicrobial 
resistance [7, 41–45]. The reaction to antibiotics of the 
studied E. coli strains showed different population stages 
of sensitivity. The behavioristic examples of the popula-
tion in response to the antibiotic are presented in Fig.  3. 
Table 4 shows detailed data, where the six groups with dif-
ferent bacterial behavior are designed in a logical way. The 
frontier zones of sensitivity and resistance represent a cut 
of value of behavior groups. The highest peak of strains 
distribution (Fig.  3) classifies the bacterial population to 
the corresponding behavior group. In the studied collec-
tion only five groups were observed. Three homogeneous 
groups represent “Sensitive”, “Intermediate”, “Resist-
ant” bacterial behavior to antibiotics. Only one antibiotic 
(tigecycline) classified all strains in the “Resistant” group. 
Two groups of bacterial behavior were named as changing: 
“Coming intermediate” and “Coming resistant” based on 
the highest number of strains on the edge of the zones of 
sensitivity and resistance. There was no identified antibiotic 
Table 3  The coincidence up to 1  mm of growth inhibition zones 
between drug resistance profiles of each pair of all E. coli strains
No. (%) of antibiotics No. (%) of paired 
strains with 1 mm 
coincidence
0 (0) 5 (0.1)
1 (2.7) 50 (1)
2 (5.41) 139 (2.5)
3 (8.11) 241 (4.3)
4 (10.8) 324 (5.7)
5 (13.5) 426 (7.5)
6 (16.2) 503 (8.9)
7 (18.9) 526 (9.3)
8 (21.6) 536 (9.5)
9 (24.3) 518 (9.1)
10 (27) 496 (8.8)
11 (29.7) 449 (7.9)
12 (32.4) 341 (6)
13 (35.1) 302 (5.3)
14 (37.8) 207 (3.7)
15 (40.5) 162 (2.9)
16 (43.2) 115 (2)
17 (45.9) 94 (1.7)
18 (48.6) 78 (1.4)
19 (51.4) 60 (1.1)
20 (54.1) 47 (0.8)
21 (56.8) 29 (0.5)
22 (59.5) 9 (0.2)
23 (62.2) 6 (0.1)
24 (64.9) 3 (0.1)
25 (67.6) 3 (0.1)
26 (70.3) 1 (0.02)
27 (73) 1 (0.02)
28 ≤ 37 (74 ≤ 100) 0 (0)
Fig. 3  The examples of inhibition zone distributions among studied 
E. coli strains with an appropriate disc potency. Each example rep-
resents an identified bacterial behavior group: Sensitive (1), Com-
ing intermediate (2), Intermediate (3), Resistant (5), Diverse (6) 
described in Table  1. The behavior groups were designed based on 
the highest peak of strain distribution in the zones of sensitivity (1), 
intermediate (3), resistance (5), on the border between the zones (2, 
4). Diverse group (6) represents more than one identified peak of fre-
quency of strains
198 Mol Biol Rep (2017) 44:191–202
1 3
which classified strains into the “Coming resistant” group. 
One group of behavior was identified as heterogeneous—
“Diverse”. These groups characterize the bacterial popula-
tion as heterogenic based on more than one highest peak of 
strains frequency in response to the antibiotic.
The analysis of the data from Table 4 led us to conclude 
that antibiotics (tigecycline) from group 5 (resistant) can-
not be used in the therapy of UTI caused by E. coli. This 
is strong evidence that the whole population is resistant to 
this antibiotic. Group 3 and 6 deserve special attention. The 
use of antibiotics from these groups is quite hazardous. It is 
strongly possible that using these antibiotics in UTI therapy 
will lead the population of E. coli to acquire resistance in 
the near future. Antibiotics from Group 3 belong mainly 
to aminoglycosides. Quinolones seem to be the most risky 
antibiotics, because they belong only to Group 6. Strains 
react very differently to these antibiotics. Also beta-lactam 
antibiotics from Group 6, which have been used for many 
years in medicine (amoxicillin, ampicillin), generated 
a large group of resistant strains of E. coli population. It 
would be good to avoid these antibiotics until the bacte-
rial population returns to the 1st group. The application of 
antibiotics from the 2nd group should also be done with 
caution and not used as often as antibiotics from the 1st 
group. The antibiotics from Group 1 seem to be the strong-
est, which is obvious because they belong to the new beta-
lactam antibiotics. The comparison of these two collections 
of E. coli strains (EUCAST and studied) revealed many dif-
ferences between behavior groups. These differences result 
from the shift of the antibiotics into the higher group of 
studied bacteria, which means increasing resistance to the 
antibiotic. The situation concerns amikacin, ceftazidime, 
imipenem, cefoxitin, netilmicin, tobramycin, tigecycline, 
amoxicillin, chloramphenicol, moxifloxacin, norfloxacin. 
It means that in Poland, these antibiotics are more popu-
lar than in the rest of Europe. The differences in the resist-
ance could be due to variation in the policy of antibiotics 
use and the pattern of antibiotic prescribing in the local 
community. A similar comparative analyses were presented 
in other articles. Konca et al. [46] presented antimicrobial 
resistance patterns depending on the region, time and other 
features, which can indicate the specific trends of antibiotic 
susceptibility patterns of clinical bacteria.
Antibiotic associations by Cohen’s kappa
The resistance profiles of studied E. coli strains were used 
for further mathematical analysis. Similarities between the 
bacterial reaction to various antibiotics were observed. 
Cohen’s kappa led to indicate specific antibiotic associa-
tions. The results discovered two different but important 
relationships between antibiotics—antibiotics present the 
same effect on the studied bacterial collection (synergis-
tic effect) (Fig. 4) and antibiotics from the same class with 
opposite reactions (contrary effect) (Table  5). To better 
understand this, there were no examples of inconsistency 
for the same drug. This does not mean that all strains were 
resistant or sensitive to the antibiotic, but the reaction to the 
antibiotic of all studied bacterial strains was statistically 
significant. We analyzed only one collection of the bacterial 
population, and Cohen kappa analysis shows how the entire 
set of strains reacts to the particular antibiotic. We could 
see which antibiotics have a similar (synergistic) or differ-
ent (antagonistic) effect on the studied bacterial population 
in this way. The inconsistency of the same antibiotic can 
be observed in the case of the analysis for different bacte-
rial collections (two different bacterial groups). The biggest 
group of the compatible antibiotics represent penicillins 
Table 4  The bacterial behavior groups to particular antibiotics characterized for the collection of reference E. coli strains (EUCAST) and for the 
studied E. coli strains based on the pattern in Fig. 3
Bolded text similarities between strains collections
Group Bacterial behavior Antibiotics (reference E. coli) Antibiotics (studied E. coli)
1 Sensitive Amoxicillin, amikacin, cefadroxil, cefalexin, 
cefepime, cefixime, cefotaxime, ceftazidime, cefti-
buten, ceftriaxone, chloramphenicol, doripenem, 
ertapenem, Imipenem, mecillinam, meropenem, 
moxifloxacin, norfloxacin
Ampicillin.sulbactam, cefadroxil, cefalexin, cefepime, 
cefixime, cefotaxime, ceftibuten, ceftriaxone, 
cefuroxime, doripenem, ertapenem, mecillinam, 
meropenem
2 Coming intermediate Amoxicillin.sulbactam, aztreonam, cefoxitin, 
netilmycin, piperacylline.tazobactam, tobramycin
Amikacin, amoxicillin.sulbactam, aztreonam, ceftazi-
dime, imipenem, piperacillin.tazobactam
3 Intermediate Ticarcillin.clavulanate, tigecycline Cefoxitin, gentamicin, netilmicin, ticarcillin.clavula-
nate, tobramycin
4 Coming resistant none none 
5 Resistant none Tigecycline
6 Diverse Ampicillin, ampicillin.sulbactam, cefuroxime, cipro-
floxacin, gentamycin, levofloxacin, nalidixic.acid, 
ofloxacin, piperacylline, ticarcillin
Amoxicillin, ampicillin, chloramphenicol, cipro-
floxacin, levofloxacin, moxifloxacin, nalidixic.acid, 
norfloxacin, ofloxacin, piperacylline, ticarcillin
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Fig. 4  The synergistic effect of antibiotics detected by Cohen’s 
kappa correlation;  A—penicillins, B—second generation of fluo-
roquinolones, C—first and third generation of caphalosporins, D—
fourth generation of fluoroquinolones. The correlation is statistically 
significant (P < 0.05, Wald test)
Table 5  The contrary effect of antibiotics from the same class detected by Cohen’s kappa
The correlation is statistically significant (P < 0.05, Wald test)
Class Antibiotic Alterable with






Piperacylline All penicillin comb




Cephalosporins 2 Cefoxitin Each other
Cefuroxime
Cephalosporins 3 Cefixime All cephalosporins 3
Cefotaxime
Ceftazidime Cefixime, cefotaxime
Ceftibuten Cefixime, cefotaxime, ceftriaxone
Ceftriaxone Cefixime, cefotaxime, ceftibuten
Quinolones Ciprofloxacin Levofloxacin, moxifloxacin
Levofloxacin Ciprofloxacin, norfloxacin, ofloxacin
Moxifloxacin Ciprofloxacin, norfloxacin, ofloxacin
Norfloxacin Levofloxacin, moxifloxacin
Ofloxacin Levofloxacin, moxifloxacin
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(A), such as ampicillin, amoxicillin and ticarcillin have 
the biggest association, and also ticarcillin with clavulanic 
acid and piperacylline in the same cluster (Fig.  4). The 
next cluster forms second  generation of fluoroquinolo-
nes: ofloxacin, ciprofloxacin and norfloxacin (B—Fig.  4), 
associated with each other. The smaller group (C—Fig. 4) 
represents the correlation between ceftriaxone (third gen-
eration of caphalosporins) and cephalexin (first generation 
of cephalosporin), and between cephalexin and cefadroxil 
(first generation of cephalosporin). The correlation between 
fourth  generation of fluoroquinolones was also observed: 
moxifloxacin and levofloxacin (D). It can constitute the 
suggestion that they can be used alternatively, because they 
revealed the same effect on the bacterial population. There-
fore, the antibiotic that causes the least side effects can be 
selected for therapy e.g. ampicillin or ticarcillin instead of 
amoxicillin. On the other hand, antibiotics from the same 
cluster should not be used in the case of reinfections. It is 
highly probable that clinical strains will possess resistance 
to all antibiotics from the same cluster presented in Fig. 4. 
This correlation can also be linked to the cross-resistance 
phenomenon in bacterial population. A similar analysis was 
presented by Obolski et al. [47] using another mathemati-
cal model. They observed a few different co-occurrence 
patterns of drug resistance of E. coli strains. The co-occur-
rence patterns most similar to our results occurred mainly 
between some penicillins and penicillin combinations.
The statistically significant inverse dependence was also 
observed in the same class of antibiotics (Table  5). This 
correlation was discovered between penicillins, penicillin 
combinations, second- and third-generation cephalospor-
ins, quinolones, aminoglycosides and others. The biggest 
group of antibiotics with a contrary effect on bacteria is 
represented by penicillin combinations. Also, they may be 
converted with all penicillins. There is a strong potential 
among them, because there is a high applicability of these 
antibiotics in the case of a resistant strain to one of them, 
alterable with each other. We also observed that the antibi-
otic has higher application potential if it belongs to a higher 
generation, for example quinolones. Levofloxacin and mox-
ifloxacin belong to a later generation in comparison to cip-
rofloxacin, norfloxacin and ofloxacin, so they characterize 
an opposite effect on the bacterial population. This corre-
lation can be a helpful tip to choose another antibiotic of 
the same class in the case of reinfection, routine or quick 
decision-making about antibiotic therapy.
A similar comparative analysis was performed in our 
previous study, where we presented the associations 
between antibiotics [8]. The presented correlations between 
antibiotics on the Kohonen maps identify the direction of 
emergence of drug resistance with high probability. The 
correlation between antibiotic co-resistance was also pre-
sented by Pathak et al. [21] and Obolski et al. [47], where 
the authors indicate that resistance to antibiotic can be 
connected with others. Also, Boonten et  al. [4] presented 
the combination of the obtained results with mathematical 
modeling to determine the quantitative effects of individual 
infection control measures. It should be emphasized that 
drug resistance of bacteria are connected with many differ-
ent features of bacteria, their host and antibiotic policy.
Summary
We demonstrated a detailed and broad approach to the anti-
biotic resistance of uropathogenic E. coli strains. The stud-
ied bacterial population make an example of pathogens, 
which can be analyzed in these ways for a better under-
standing of their associations with antibiotic therapy. The 
conclusions were drawn based on the statistically signifi-
cant results, but they concern only one bacterial population. 
The state of antibiotic profiles have changed in 10 years. 
These results should be verified by fresh bacterial collec-
tion. However, the results were compared to the drug resist-
ance profile from EUCAST data. We should also remem-
ber the potential different pathways of bacterial adaptation 
to survive in environments with antibiotic. Based on the 
observed findings we would like to pay special attention to 
several important aspects:
1. IR spectra with the correlations of artificial neural net-
work may be taken into account for routine and quick 
diagnostic of MDR strains.
2. Ward’s hierarchical clustering method based on the 
diameter zone of inhibited growth of bacterial strains 
could be used for clonal and epidemiological bacterial 
differentiation.
3. The use of tigecycline should be reconsidered against 
uropathogenic E. coli strains.
4. Fluoroquinolones as well as ampicillin, piperacylline 
and ticarcillin seem to be the most risky antibiotics, 
because they represent bacterial behavior belonging 
only to Group 6 (Diverse).
5. Both Table  3 and Fig.  4 may be the starting point to 
create a helpful model when deciding on what antibi-
otic to select against UPEC.
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